Indications for Use of Amfepramone
Amfepramone is powerful weight loss pills, providing a great effect on the cardiovascular and central nervous systems (CNS) and hence not all the patients with obesity can use them.
To buy Amfepramone (Diethylpropion) weight loss pills at pharmacy, prescription is needed. Patients, who want to use Amfepramone, should undergo a medical examination.
Amfepramone is prescribed to those patients only, who were diagnosed obesity (BMI over 30). Patients with overweight (BMI 25 to 30) are never prescribed with Amfepramone weight loss pills, even if they suffer from hypertension, diabetes type 2 and high levels of blood lipids.
Amfepramone weight loss pills are indicated to those patients, who failed to lose weight by means of diets and physical activity. If Amfepramone was prescribed for obesity treatment, it doesn’t mean that a patient can eat any food he likes and lead a sedentary lifestyle.
Amfepramone is no magic slimming pills. Amfepramone is indicated only as an adjunct to a weight loss program. When using Amfepramone, the appetite is greatly suppressed and so a patient can and must lessen the amount of high-calorie food in his diet.
Amfepramone slimming pills are also prescribed to patients with general or abdominal obesity. Amfepramone is evenly effective for different types of obesity and so it can be used regardless of a patient’s gender or obesity severity.
Amfepramone is intended for a short-term treatment. Optimal time of use of Amfepramone slimming pills is 35-50 days. A long-term use of diet pills can reduce the efficiency of Amfepramone and cause either psychological or physical dependence.
Amfepramone is indicated to obese patients, who have no moderate or severe diseases of the CNS and the cardiovascular system.
Amfepramone diet pills must not be prescribed in:
- History of alcohol or drug abuse.
- High blood pressure.
- Allergy or hypersensitivity to Amfepramone.
- Pregnancy or breastfeeding.
- Usage of any other diet pills.
- Depressive disorders and other CNS diseases.
- Heart valve diseases.